Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

Untangling the ErbB signalling network

2001 • 6,623 citations

Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets

2000 • 2,694 citations

Tumor Antigens Recognized by T Lymphocytes

1994 • 1,238 citations

A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

1998 • 712 citations

NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway

2000 • 690 citations

Lymphocyte-Mediated Cytotoxicity And Blocking Serum Activity To Tumor Antigens

1974 • 651 citations

CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4

1997 • 612 citations

Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-Specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis

2001 • 589 citations

Predominant Role for Directly Transfected Dendritic Cells in Antigen Presentation to CD8+ T Cells after Gene Gun Immunization

1998 • 569 citations

Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization.

1997 • 566 citations

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.

1996 • 561 citations

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

1998 • 530 citations

Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

1994 • 467 citations

The intriguing role of polymorphonuclear neutrophils in antitumor reactions

2001 • 411 citations

Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies

1985 • 408 citations

B cells inhibit induction of T cell-dependent tumor immunity

1998 • 393 citations

Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells

2002 • 355 citations

DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice

2000 • 354 citations

Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy

2000 • 349 citations

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

1991 • 335 citations

Fc receptors are required in passive and active immunity to melanoma

1998 • 322 citations

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.

1981 • 317 citations

CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung

2002 • 309 citations

Perforin Is a Major Contributor to NK Cell Control of Tumor Metastasis

1999 • 290 citations

Immune complex–mediated antigen presentation induces tumor immunity

2002 • 276 citations

Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

2001 • 236 citations

Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical events

1999 • 230 citations

Immune complex–mediated antigen presentation induces tumor immunity

2002 • 221 citations

Serological analysis of human tumor antigens: molecular definition and implications

1997 • 216 citations

Combination therapy with trastuzumab (Herceptin) and cisplatin for chemoresistant metastatic breast cancer: evidence for receptor-enhanced chemosensitivity.

1999 • 182 citations

A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors

1997 • 178 citations

Cytokines, tumour-cell death and immunogenicity: a question of choice

1997 • 168 citations

Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts.

1997 • 157 citations

The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.

2001 • 157 citations

Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo.

1988 • 155 citations

Antibodies against p53 are associated with poor prognosis of colorectal cancer

1995 • 142 citations

An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.

1994 • 130 citations

Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine.

2000 • 116 citations

Prevention of breast tumour development in vivo by downregulation of the p185neureceptor

1995 • 114 citations

Gamma Interferon (IFN-γ) Receptor Null-Mutant Mice Are More Susceptible to Herpes Simplex Virus Type 1 Infection than IFN-γ Ligand Null-Mutant Mice

1999 • 112 citations

DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors.

1998 • 107 citations

Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer.

1997 • 97 citations

Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.

1990 • 91 citations

p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma

2000 • 84 citations

Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs

1999 • 83 citations

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes: either CD4+ or CD8+ T cells can promote survival and recovery after challenge

2000 • 76 citations

Vaccination with Cytoplasmic ErbB-2 DNA Protects Mice from Mammary Tumor Growth Without Anti-ErbB-2 Antibody

2001 • 70 citations

Helper strategy in tumor immunology: Expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy

1988 • 69 citations

CD4+ AND B LYMPHOCYTES IN TRANSPLANTATION IMMUNITY

1993 • 65 citations

Enhanced Humoral Immune Response Correlates With Improved Disease-Free and Overall Survival in American Joint Committee on Cancer Stage II Melanoma Patients Receiving Adjuvant Polyvalent Vaccine

2002 • 60 citations

Vaccination with Her-2/neu DNA or protein subunits protects against growth of a Her-2/neu-expressing murine tumor

2001 • 55 citations

Antitumor vaccines: is it possible to prevent a tumor?

2002 • 48 citations

DNA cancer vaccines: A gene gun approach

1997 • 47 citations

Cancer vaccines, a critical review--Part I.

2002 • 47 citations

IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but not IgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases.

1998 • 44 citations

In vitro reeducated T helper cells from sarcoma-bearing mice inhibit sarcoma growth in vivo.

1984 • 39 citations

Synergy between an antibody and CD8⁺ cells in eliminating an established tumor

1997 • 37 citations

Correlation Between Natural and Antibody-Dependent Cell-Mediated Cytotoxicity Against Tumor Targets in the Mouse. II. Characterization of the Effector Cells

1979 • 36 citations

HER2 peptide-specific CD8+ T cells are proportionally detectable long after multiple DNA vaccinations

2002 • 24 citations